Tanakan Side Effects

8348294-4 | Tongue Oedema, Fear, Dysphagia, Speech Disorder
on Apr 23, 2012 Male patient from DENMARK , 59 years of age, was diagnosed with abdominal pain upper and was treated with Tanakan(View Usage). Patient experienced the following unwanted or unexpected effects: tongue oedema, fear, dysphagia, speech disorder. Tanakan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (150 Mg;po) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

8025459-2 | Renal Cancer
Patient was taking Tanakan (View Usage). Patient had the following side effects: renal cancer on Dec 28, 2011 from ROMANIA Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with cerebral ischaemia, hypertension, myocardial ischaemia, hyperuricaemia, atrial fibrillation (What is atrial fibrillation?), prostatic adenoma, arteriosclerosis and. Tanakan dosage: . During the same period patient was treated with AMLODIPINUM (View Amlodipinum Review and Amlodipinum Label ), TRIMETAZIDINUM (View Trimetazidinum Review and Trimetazidinum Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIGOXIN (1/2 Tablet Every Other Day) (View Digoxin Review and Digoxin Label ), INDAPAMID (View Indapamid Review and Indapamid Label ), TELMISARTAN (View Telmisartan Review and Telmisartan Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), PLAVIX (View Plavix Review and Plavix Label ).

7996250-8 | Off Label Use, Pruritus
Adverse event was reported on Dec 16, 2011 by a Female patient taking Tanakan (View Usage) (Dosage: ) was diagnosed with angiopathy, malabsorption, osteoporosis (What is osteoporosis?) and. Location: FRANCE , 64 years of age, After Tanakan was administered, patient had the following side effects: off label use, pruritus. During the same period patient was treated with CREON (4 Capsules, Once) (View Creon Review and Creon Label ), BONIVA (View Boniva Review and Boniva Label ).

7903683-4 | Iron Deficiency Anaemia, Functional Gastrointestinal Disorder, Varices Oesophageal
on Nov 02, 2011 Male patient from FRANCE , 69 years of age, weighting 235.9 lb, was diagnosed with pain (What is pain?) and was treated with Tanakan (View Usage). Patient experienced the following unwanted or unexpected effects: iron deficiency anaemia, functional gastrointestinal disorder, varices oesophageal. Tanakan dosage: 120 Mg, Qd. During the same period patient was treated with PRAVASTATIN (20 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), MICROLAX [GLYCEROL,SODIUM CITRATE ACID,SODIUM LAURYL SULFATE,SORBI (Unk) (View Microlax [glycerol,sodium Citrate Acid,sodium Lauryl Sulfate,sorbi Review and Microlax [glycerol,sodium Citrate Acid,sodium Lauryl Sulfate,sorbi Label ), SPASFON (6 Cp) (View Spasfon Review and Spasfon Label ), ATORVASTATIN CALCIUM (Daily Dose 10 Mg) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ZOLPIDEM TARTRATE (Daily Dose 10 Mg) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MORPHINE SULFATE (30 Mg, Qid) (View Morphine Sulfate Review and Morphine Sulfate Label ), TARKA (Daily Dose 180 Mg) (View Tarka Review and Tarka Label ). Patient was hospitalized.


7878741-3 | Haemolytic Anaemia
on Oct 20, 2011 Female patient from FRANCE , 78 years of age, was diagnosed with dementia alzheimer's type, thrombosis prophylaxis, epilepsy (What is epilepsy?), sensation of heaviness, calcium deficiency and was treated with Tanakan(View Usage). Patient had the following side effects: haemolytic anaemia. Tanakan dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DEPAMIDE (View Depamide Review and Depamide Label ), GALANTAMINE HYDROBROMIDE (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ), MEMANTINE HYDROCHLORIDE (View Memantine Hydrochloride Review and Memantine Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DIOSMIN (View Diosmin Review and Diosmin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

7682735-0 | Vertigo, Cytolytic Hepatitis, Antinuclear Antibody Positive, Hypergammaglobulinaemia, Vomiting, Nausea
Patient was taking Tanakan (View Usage). After Tanakan was administered, patient had the following side effects: vertigo, cytolytic hepatitis, antinuclear antibody positive, hypergammaglobulinaemia, vomiting, nausea (What is nausea?) on Aug 02, 2011 from FRANCE Additional patient health information: Male patient , 44 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Tanakan dosage: . During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ).

7474610-1 | Hallucination, Visual
Adverse event was reported on Apr 19, 2011 by a Female patient taking Tanakan (ginkgo Biloba Extract) (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: ITALY , 70 years of age, Patient experienced the following unwanted or unexpected effects: hallucination, visual. During the same period patient was treated with PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), NEBIVOLOL HCL (5 Mg (5 Mg, 1 In 1 D), Oral) (View Nebivolol Hcl Review and Nebivolol Hcl Label ). Patient was hospitalized.

7302069-3 | Intracranial Pressure Increased, Headache, Blood Pressure Increased, Off Label Use, Somnolence, Vomiting Projectile, Cerebral Haemorrhage, Lacunar Infarction, Depressed Level Of Consciousness
on Feb 08, 2011 Male patient from BELGIUM , 78 years of age, was diagnosed with vertigo and was treated with Tanakan (View Usage). Patient had the following side effects: intracranial pressure increased, headache (What is headache?), blood pressure increased, off label use, somnolence, vomiting projectile, cerebral haemorrhage, lacunar infarction, depressed level of consciousness. Tanakan dosage: . During the same period patient was treated with BEFACT FORTE (View Befact Forte Review and Befact Forte Label ), PLAVIX (View Plavix Review and Plavix Label ), OMIC (View Omic Review and Omic Label ). Patient was hospitalized and became disabled.

5336904-5 | Phlebitis
on May 16, 2007 Female patient from FRANCE , 80 years of age, was diagnosed with transient ischaemic attack and was treated with Tanakan(View Usage). After Tanakan was administered, patient had the following side effects: phlebitis. Tanakan dosage: Unk. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), SECTRAL (Unk) (View Sectral Review and Sectral Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5335022-X | Phlebitis
Patient was taking Tanakan (View Usage). Patient experienced the following unwanted or unexpected effects: phlebitis on May 16, 2007 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with transient ischaemic attack and. Tanakan dosage: Unk. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), SECTRAL (Unk) (View Sectral Review and Sectral Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), PLAVIX (View Plavix Review and Plavix Label ).